Continuous Monitoring of Alcohol Use by Wearable Biosensors -- SBIR Fast-Track Award
Award Notice Posted
- Solicitation number
- 75N94020C00005
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Giner, Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N94020C00005 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Auburndale MA 02466 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This SBIR Fast-Track contract was awarded by the National Institute on Alcohol Abuse and Alcoholism to GINER, INC. for the development of a wearable, continuous alcohol monitoring biosensor. The base contract of $249,997 will fund a Phase I study to validate an enzymatic biosensor that can detect and monitor blood alcohol concentration in real-time directly from interstitial fluid. The contract also contains an option for a Phase II study, which upon exercise would further refine the sensor probe prototype into a compact, lightweight device demonstrating commercialization potential and ready for research evaluating its effectiveness.
Notice text
The research under this contract is toward the development of next-generation, wearable continuous alcohol monitoring (CAM) technology designed to measure, record, and store Blood Alcohol Concentration (BAC) in real time. This SBIR “Fast-Track”-type contract contains a base contract requirement for an SBIR Phase I Study and a contract option for an SBIR Phase II Study.
This SBIR contract is awarded under NIAAA Topic Area 018, "Alcohol Biosensor Development for Continuous Alcohol Consumption Monitoring", contained in SBIR Solicitation PHS 2020-1.
The SBIR Phase I Study (base contract requirement) will perform analysis toward validating the technology of a new, discreet, wearable, stable, selective and highly sensitive enzymatic biosensor and algorithms that can detect alcohol in real-time and directly from interstitial fluid and evaluate its concentration in a mixture similar to human serum.
The SBIR Phase II Study (contract option) will further refine and optimize the performance of the sensor probe and integrate it into a compact, lightweight prototype device ready to use in research studies that will effectively demonstrate its potential to private investors to support commercialization.
Awarded contract 75N94020C00005 to GINER, INC. for 2499714.00 on 2020-09-02.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity